High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden

被引:33
作者
Hanberger, H [1 ]
Hoffmann, M
Lindgren, S
Nilsson, LE
机构
[1] Linkoping Univ Hosp, Dept Infect Dis, S-58185 Linkoping, Sweden
[2] Linkoping Univ Hosp, Dept Clin Pharmacol, S-58185 Linkoping, Sweden
[3] Linkoping Univ Hosp, Dept Hosp Pharm, S-58185 Linkoping, Sweden
[4] Linkoping Univ Hosp, Dept Clin Microbiol, S-58185 Linkoping, Sweden
关键词
D O I
10.3109/00365549709035904
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The frequency of antibiotic resistance among bacteria in 4 intensive care units (ICUs) at a university hospital in Sweden was investigated annually from 1993 to 1996. rin increase in ampicillin-resistant enterococci from 1993 to 1995 was seen which was due to a shift from Enterococcus faecalis to Enterococcus faecium. After a special infection control programme was instituted, the rate of ampicillin resistance among enterococci and the number of E. faecium isolates declined during 1996. The oxacillin resistance rates for Staphylococcus aureus were less than or equal to 2%, while most of the coagulase-negative staphylococci (CNS) were oxacillin resistant. No vancomycin-resistant enterococci or staphylococci were seen. The ciprofloxacin resistance rates for CNS and Enterococci spp. were high. Relatively high levels of resistance to cefotaxime and piperacillin/tazobactam among Enterobacter spp. were also seen. During 1995 and 1996 Pseudomonas aeruginosa showed increasing resistance to ceftazidime, ciprofloxacin and piperacillin/tazobactam. This was due to an outbreak among rather few patients. The overall resistance rates for Gram-negative bacteria were low for aminoglycosides and imipenem. From 1993 to 1996 the total antibiotic consumption decreased by 27% in the whole hospital and 16.5% in the ICUs. However, the reduced antibiotic consumption was paralleled with a 23% decrease in the total number of patients treated in the hospital from 1993 to 1996. In contrast there was an 11.5% increase in the number of ICU patients treated during this period. The conclusion is that all ICUs within a hospital should have a programme for 'on-line' antibiotic resistance surveillance of drugs used in that unit in order to change the empiric treatment when there is an increase in antibiotic resistance. It is also important to survey the antibiotic consumption in the ICUs in order to avoid further selective pressure on bacteria showing increased resistance rates.
引用
收藏
页码:607 / 614
页数:8
相关论文
共 26 条
  • [1] Usage of antibacterial and antiparasitic drugs in animals in Sweden between 1988 and 1993
    Bjornerot, L
    Franklin, A
    Tysen, E
    [J]. VETERINARY RECORD, 1996, 139 (12) : 282 - 286
  • [2] Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci
    Bonten, MJM
    Hayden, MK
    Nathan, C
    vanVoorhis, J
    Matushek, M
    Slaughter, S
    Rice, T
    Weinstein, RA
    [J]. LANCET, 1996, 348 (9042) : 1615 - 1619
  • [3] ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY
    CHOW, JW
    FINE, MJ
    SHLAES, DM
    QUINN, JP
    HOOPER, DC
    JOHNSON, MP
    RAMPHAL, R
    WAGENER, MM
    MIYASHIRO, DK
    YU, VL
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 585 - 590
  • [4] CUNHA BA, 1994, HEART LUNG, V23, P361
  • [5] SUSCEPTIBILITY TO BETA-LACTAM ANTIBIOTICS AND GENTAMICIN OF GRAM-NEGATIVE BACILLI ISOLATED FROM HOSPITALIZED-PATIENTS - A SWEDISH MULTICENTER STUDY
    DORNBUSCH, K
    BENGTSSON, S
    BRORSON, JE
    FRITZ, H
    HENNING, C
    KRONVALL, G
    LARSSON, P
    MALMBORG, AS
    THORE, M
    TARNVIK, A
    WALDER, M
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1988, 20 (06) : 641 - 647
  • [6] RESISTANCE TO BETA-LACTAM ANTIBIOTICS AND CIPROFLOXACIN IN GRAM-NEGATIVE BACILLI AND STAPHYLOCOCCI ISOLATED FROM BLOOD - A EUROPEAN COLLABORATIVE STUDY
    DORNBUSCH, K
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (02) : 269 - 278
  • [7] DORNBUSCH K, 1995, 7 EUR CLIN MICR INF, P50
  • [8] Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins
    FungTomc, JC
    Gradelski, E
    Huczko, E
    Dougherty, TJ
    Kessler, RE
    Bonner, DP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) : 1289 - 1293
  • [9] RISK-FACTORS FOR ACQUISITION OF MULTIPLY DRUG-RESISTANT GRAM-NEGATIVE BACTERIA
    GOULD, IM
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 : 30 - 38
  • [10] HANBERGER H, 1997, CLIN MICROBIOL INFEC, V3, P215